Medikra Inc. (MDKR)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	165.55M
Revenue (ttm)	16,099 -61.7%
Net Income	-776,370
EPS	-0.03
Shares Out	30.10M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About MDKR

Medikra is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical-grade botanical therapeutics. Through its wholly owned Malaysian subsidiary, Medika Natura Sdn. Bhd., the Company has established an integrated discovery and development platform that combines proprietary botanical extraction, preclinical and clinical trials, and multi-omics research. This platform aims to transform traditional medicinal plants into scientifically tested therapies aligned with international regula...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 10
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: MDKR

Financial Performance

Data Source: SEC filings Last updated: Aug 20, 2026

The data for this page was gathered manually by the Stock Analysis team, from official company filings available on SEC.gov.

Data Sources Report a data error